These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 968493)

  • 1. [Hepato-toxic risk of rifampicin].
    Emerit J
    Sem Hop Ther; 1976; 52(5-6):311-3. PubMed ID: 968493
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of adverse reactions of chronic drug therapy as examplified with the hepatotoxic action of isoniazid and rifampicin].
    Bartmann K
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1518-29. PubMed ID: 347784
    [No Abstract]   [Full Text] [Related]  

  • 3. [Toxic hepatitis (liver and antitubercular drugs)].
    Kohan S
    Acta Gastroenterol Latinoam; 1977 Dec; 7(4):301-4. PubMed ID: 617560
    [No Abstract]   [Full Text] [Related]  

  • 4. [Animal experimental studies on the problem of liver damage by antitubercular agents (rifampicin and isoniazide) by means of the galactosamine model].
    Leinweber B; Mahrt R
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():300-3. PubMed ID: 1029192
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatopathy and functional acute renal insufficiency due to rifampicin].
    Errasti P; Otero R; Purroy A
    Rev Clin Esp; 1978 May; 149(3):295-8. PubMed ID: 694100
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepato-biliary effects of rifampicin in rats].
    Rozé C; Camilleri JP; Vaille C; Souchard M; Debray C
    Med Chir Dig; 1976 May; 5(6):373-7. PubMed ID: 1011900
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cholestatic hepatitis during treatment with I.N.H. and rifampicin: arguments in favour of the hepatotoxicity of rifampicin (author's transl)].
    Poupon RY; Meyniel D; Petit J; Gustot P; Darnis F
    Ann Med Interne (Paris); 1979; 130(6-7):371-5. PubMed ID: 496138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The hepatotoxicity of rifampicin and its modification through "essential" choline phospholipids].
    Kuntz HD; Rausch V; Bammel E
    Med Welt; 1978 Mar; 29(11):452-4. PubMed ID: 651600
    [No Abstract]   [Full Text] [Related]  

  • 9. [Detection of the effects of the rifampin-isoniazid combination on the human liver].
    Plomteux G; Heusghem C; Ferdinande R; Lecoq A; Winandy A; Parmentier JC
    Nouv Presse Med; 1974 Mar; 3(12):727-32. PubMed ID: 4836506
    [No Abstract]   [Full Text] [Related]  

  • 10. Present views on isoniazid and isoniazid-rifampicin hepatitis.
    Pessayre D
    Agressologie; 1982 Jan; 23(A):13-5. PubMed ID: 7081577
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug-induced hepatitis during a treatment associating isoniazid and rifampicin].
    Jean R; Bonnet H; Pages P; Dumas R; Greze J
    Ann Pediatr (Paris); 1972 Apr; 19(4):307-11. PubMed ID: 5075678
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rifampicin-induced hepatitis in childhood].
    Bedir O; Yalcin E; Eskinasis N
    Monatsschr Kinderheilkd (1902); 1978 May; 126(5):337-9. PubMed ID: 651930
    [No Abstract]   [Full Text] [Related]  

  • 13. [Icterus caused by rifampicin and isoniazide].
    Haber I; Hubens H; Buyssens N
    Tijdschr Gastroenterol; 1974; 17(3):165-76. PubMed ID: 4454055
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental study of liver damage due to rifampicin and rifampicin-isoniazid combination].
    Rossolini A; Cellesi C; Debolini A
    Farmaco Prat; 1973 Jun; 28(6):345-55. PubMed ID: 4714054
    [No Abstract]   [Full Text] [Related]  

  • 15. [A case of allergic drug-induced hepatitis suspected with rifampicin-induced antinuclear antibody].
    Matsui S; Nakazawa T; Dobashi K; Mori M
    Arerugi; 1994 Oct; 43(10):1280-2. PubMed ID: 7826225
    [No Abstract]   [Full Text] [Related]  

  • 16. [Isoniazid-rifampicin: a model for hepatotoxicity and for bibliographic Anglomania].
    Toulet J; Viteau JM
    Gastroenterol Clin Biol; 1978; 2(8-9):756-7. PubMed ID: 361483
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hepatoxic effects of rifampicin].
    Lechner HJ; Reimers D
    Prax Pneumol; 1973 Apr; 27(4):241-9. PubMed ID: 4698443
    [No Abstract]   [Full Text] [Related]  

  • 18. [The liver and rifampicin].
    Piéron R; Marien C; Jagueux M
    Cah Med; 1973 Jun; 14(6):447-51. PubMed ID: 4766668
    [No Abstract]   [Full Text] [Related]  

  • 19. [Jaundice and rifampicin. Critical study].
    Nebout T; Dhumeaux D; Berthelot P
    Nouv Presse Med; 1974 Mar; 3(12):733-6. PubMed ID: 4836507
    [No Abstract]   [Full Text] [Related]  

  • 20. [Interference of rifampicin on liver cytology].
    Bertelli A; Tongiani R; Chieli E; Malvaldi G
    Med Chir Dig; 1976 May; 5(6):345-8. PubMed ID: 1011896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.